IQV earnings

Catalyst

IQV earnings

IQV earnings — 2026-05-05

Reported the quarter ending 2026-03-31: revenue $4.15B, diluted EPS $1.61, net income $274M (SEC filing). Across the print the stock moved +9.6% (close before → first close after).

Backfilled from filed financials — a record of the print, not an analyst read.

8 events
DateTypeEvent
Apr 28 ScanBiotech Scan Apr 26 ArticleDaily Actions Apr 26 ScanHealthcare Scan Apr 26 ScanBiotech Scan Apr 26 TargetIQV stop-loss - $140.00 May 29 ScanBiotech Scan Apr 10 Deep DiveIQV Deep Dive Jun 4 Market SignalBiotech Funding Gate

No direct external sources are attached to this read.